ComplianceOnline

Why and How - Verification of Compendial Methods - USP <1226>

Instructor: Nanda Subbarao
Product ID: 701752
Training Level: Intermediate to Advanced
  • 16
  • February 2017
    Thursday
  • 10:00 AM PST | 01:00 PM EST
    Duration: 90 Min

Live Online Training
February 16, Thursday 10:00 AM PST | 01:00 PM EST
Duration: 90 Min

$229.00
One Dial-in One Attendee
$499.00
Group-Max. 10 Attendees/Location
(For multiple locations contact Customer Care)

Customer Care

Fax: +1-650-963-2556

Email: customercare@complianceonline.com

Read Frequently Asked Questions

This webinar will provide an in-depth discussion of USP <1226>, 'Verification of Compendial Methods' requirements. We will discuss FDA 483s on the subject of Method Verification to understand current FDA expectations.

Why Should You Attend:

This webinar will provide an in-depth discussion of USP <1226>, 'Verification of Compendial Methods' requirements. Conditions under which Methods can be classified as 'basic' and not require verification will be discussed. The factors under actual conditions of use which impact method performance and make method verification necessary will be addressed. FDA 483s on the subject of Method Verification will be discussed to understand current FDA expectations for verification of compendial methods.

Areas Covered in the Webinar:

  • FDA 483s related to method verification.
  • Requirements of USP <1226>, 'Verification of Compendial Methods'
  • What are the current FDA expectations related to method verification.
  • What are the factors which impact method performance under actual condition of use?

Who Will Benefit:

  • QC personnel
  • QC Supervisors and Management
  • QA personnel
  • QA Management
  • Documentation management specialists
  • Regulatory affairs personnel
  • R&D Lab personnel
  • R&D Lab Supervisors
Instructor Profile:
Nanda Subbarao

Nanda Subbarao
Senior Consultant, Biologics Consulting Group

Dr. Subbarao, holds a Ph.D. in Bio-organic Chemistry. She is currently a Senior Consultant with the Biologics Consulting Group specializing in Analytical, Stability, CMC and GLP/GMP Quality Systems. Her hands-on industrial experience covers stability and laboratory cGMP systems for both biologics and conventional drugs. As a consultant she has assisted pharma and biotech organizations in evaluation of analytical methods and method validation for a wide range of products ranging from conventional drugs to well characterized proteins and vaccines, from pre-clinical phase to commercial phases. She has been involved several times over her career in projects to setup or upgrade cGMP/GLP complaint Quality Systems for laboratory and stability programs for products during development and in commercial phase. She serves on the AAPS Stability Focus Group Steering Committee.

Follow us :
ComplianceOnline Banking Summit 2016 | Risk Management and Data Security - 80390SEM
ComplianceOnline Medical Device Summit 2017

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product! Write review

Best Sellers
You Recently Viewed
    Loading